Applications of contrast-enhanced ultrasound in gynecological diseases

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030635

Enrollment

Unknown

Registered

2020-03-08

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecological diseases

Interventions

Gold Standard:Surgical pathology

Index test:1.&#32

Contrast-enhanced&#32

ultrasound

2.&#32

Transvaginal&#32

ultrasonography.

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Female patients with endometrial thickening or abnormality on coventioanl ultrasound and with pathological results;Or 2. Female patients with high-risk HPV infection and/or liquid-based cytological abnormalities with histopathological findings; Or 3. Female patients with adnexa lesions on conventional ultrasound and had pathological results; Or 4. Patients with cervical cancer requiring adjuvant chemotherapy.

Exclusion criteria

Exclusion criteria: 1. The patient refuses to cooperate; 2. Contraindications of contrast-enhanced ultrasound; 3. Severe heart, liver, lung and other serious diseases.

Design outcomes

Primary

Measure	Time frame
contrast-enhanced ultrasound;SEN, SPE, ACC, AUC of ROC, +PV, -PV;	—

Countries

China

Contacts

Public ContactXinling Zhang

The Third Affiliated Hospital of Sun Yat-Sen University

zhxl40630@163.com+86 18922103373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026